Press Releases

Optibrium and Molecular Networks Collaborate to Share Complementary Technology Platforms

CAMBRIDGE, United Kingdom and ERLANGEN, Germany, September 15, 2009 – Optibrium Ltd. and Molecular Networks GmbH today announce plans to further intensify their collaboration and share complementary technology platforms. The companies demonstrated their cooperation with the integration of Molecular Networks' premium 3D structure generator CORINA into StarDrop, Optibrium's intuitive platform for guiding compound selection and design decisions in drug discovery.

Chemical Computing Group and Molecular Networks Announce the Integration of CORINA into MOE

MONTREAL, Canada and ERLANGEN, Germany, October 8, 2007 - Chemical Computing Group Inc. (CCG) and Molecular Networks GmbH today announce the integration of CORINA, Molecular Networks' premium three-dimensional molecular model-generating program into CCG's comprehensive and powerful life science modeling suite Molecular Operating Environment, MOE. The integration technology will be included in the 2007.09 version of CCG's Molecular Operating Environment (MOE).

BioSolveIT and Molecular Networks Announce Collaboration for Joint Marketing on the North American Market

St. Augustin and Erlangen, Germany, August 2, 2007 - BioSolveIT GmbH and Molecular Networks GmbH today announced that they are intensifying their collaboration and marketing activities on the US-American and Canadian market. The two companies have signed an agreement whereby BioSolveIT, respected worldwide for its docking tool FlexX, will also market Molecular Networks' products such as CORINA - the industry benchmark for 3D structure generation - in North America. Effective immediately, BioSolveIT's US sales representative Dr. Marguerita Lim-Wilby will act as the point person for any product and license inquiries for both companies.

Inte:Ligand and Molecular Networks annouce the integration of CORINA into ILIB DIVERSE

Vienna, Austria and Erlangen, Germany - April 26, 2005 - Inte:Ligand and Molecular Networks today announce the integration of CORINA, the industry leading software for the generation of three-dimensional molecular models, into ILIB DIVERSE, the high quality virtual compound library generation platform of Inte:Ligand. The two companies are also announcing their intention to share complementary technology for mutual benefit in the future.

BioSolveIT GmbH and Molecular Networks GmbH Win BMBF Funding for EUR 2 Million Project

St. Augustin and Erlangen, Germany - October 6, 2004 - BioSolveIT GmbH and Molecular Networks GmbH today announced that they have been awarded a threeyear development grant from the BMBF, through its BioChance+ programme. With the NovoBench project, the German ministry supports the development of a new technology platform for de novo design of lead compounds with high propensity of being biologically active and synthetically feasible. The heart of this platform is an integrated collection of virtual screening tools that facilitate in silico synthesis of chemical fragments optimized towards certain target-dependent properties.

SciTegic and Molecular Networks Announce the Integration of CORINA into Pipeline Pilot

SAN DIEGO, CA and ERLANGEN, GERMANY - December 2, 2003 - SciTegic® and Molecular Networks GmbH today announce the integration of CORINA, the industry-leading software for the generation of 3D molecular structures, into Pipeline Pilot, SciTegic's data pipelining software platform. The Pipeline Pilot integration component released today will allow customers of CORINA and Pipeline Pilot to seamlessly generate high quality 3D structures from within their data processing protocols.

Biomax Informatics AG and Molecular Networks GmbH Announce Product Development Alliance

Martinsried and Erlangen, Germany - July 9, 2001 - Biomax Informatics and Molecular Networks announce today the formation of a strategic partnership that will effectively join bioinformatics and chemoinformatics into one stream of research. Molecular Networks, which specializes in the development of software for drug design, combinatorial chemistry, and data-mining, and Biomax, with its expertise in DNA and protein sequence analysis used in drug-target design and database integration, will collaborate in the development of software tools for optimized drug-target lead generation and validation.

MDL and Molecular Networks Partner to Include CORINA 3D Models in MDL Databases

-Free AIDS Database is First Product Release-

San Leandro, California and Erlangen, Germany - March 15, 2001 - MDL Information Systems, Inc., the recognized leader in discovery informatics for the life sciences and chemistry in industry and academia, and Molecular Networks GmbH, makers of the premium three-dimensional molecular model-generating program CORINA, announced today that new versions of MDL databases will feature CORINA-generated models. By replacing the existing structural models in its content databases, MDL will provide researchers with a more complete and realistic set of searchable models in an industry-standard format.